Clinic
The Roads Foundation, INC.
The Roads Foundation, INC. was paid $59.32M by Medicaid between Jan 2018 and Dec 2024, across 193 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 82% of everything it billed.
33Billing provider infoTHE ROADS FOUNDATION, INC.
COMPTON, CA 90221
COMPTON, CA 90221
33aNPI1508278359assigned 05/28/2014
33bProvider typeClinic/Center
28Total paid$59.32M
24GClaims839,110
24DCodes billed193
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in California
Rank by total paid#7 of 504
Median peer was paid$102K
This provider vs. median583×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 68,804 | $5.03M | |
| 2019 | 86,142 | $4.94M | |
| 2020 | 97,026 | $5.97M | |
| 2021 | 98,954 | $7.26M | |
| 2022 | 111,977 | $7.50M | |
| 2023 | 166,268 | $12.53M | |
| 2024incomplete | 209,939 | $16.10M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 82% | 335,781 | 269,474 | $48.43M |
| 00003 | Internal/system code - not a standard HCPCS code | 9.8% | 31,231 | 24,143 | $5.80M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.8% | 168,011 | 140,842 | $2.28M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.4% | 30,401 | 28,185 | $809K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 9,953 | 8,057 | $483K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 5,018 | 4,812 | $335K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 2,595 | 2,590 | $294K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 942 | 938 | $101K |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 6,755 | 5,104 | $96K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | <1% | 2,740 | 2,321 | $75K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 2,451 | 1,508 | $43K |
| J3490 | Unclassified drugs | <1% | 660 | 592 | $40K |
181 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 3,013 | $35K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 754 | $34K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 2,057 | $34K |
| 90837 | Psychotherapy session, about an hour | <1% | 741 | $32K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 682 | $31K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,595 | $27K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,146 | $22K |
| 0011A | <1% | 710 | $21K | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 678 | $18K |
| 0001A | <1% | 737 | $17K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,455 | $16K |
| 0012A | <1% | 577 | $16K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,890 | $14K |
| 0002A | <1% | 582 | $14K | |
| 99000 | <1% | 30,594 | $14K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 3,075 | $12K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,857 | $11K |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 1,042 | $9K |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 314 | $8K |
| 0064A | <1% | 281 | $8K | |
| 90670 | <1% | 1,321 | $7K | |
| 90651 | <1% | 1,458 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 11,175 | $7K |
| 81025 | <1% | 5,658 | $5K | |
| 90686 | <1% | 3,365 | $5K | |
| 90658 | <1% | 1,681 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 30,535 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,374 | $5K |
| 0031A | <1% | 125 | $4K | |
| 80061 | Lipid panel | <1% | 4,332 | $4K |
| 90723 | <1% | 1,377 | $4K | |
| 90648 | <1% | 1,990 | $4K | |
| 90734 | <1% | 986 | $4K | |
| 90710 | <1% | 797 | $4K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 450 | $3K |
| 99384 | <1% | 242 | $3K | |
| 11721 | <1% | 771 | $3K | |
| G9920 | Screening performed and negative | <1% | 107 | $3K |
| 90633 | <1% | 1,522 | $3K | |
| 83655 | <1% | 1,977 | $3K | |
| 82948 | <1% | 14,235 | $2K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 329 | $2K |
| 99401 | <1% | 5,153 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,211 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,894 | $2K |
| 0004A | <1% | 117 | $2K | |
| 90685 | <1% | 468 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,520 | $2K |
| 83721 | <1% | 4,243 | $2K | |
| 90715 | <1% | 616 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 606 | $2K |
| 0054A | <1% | 68 | $2K | |
| 99383 | <1% | 249 | $1K | |
| 90680 | <1% | 772 | $1K | |
| 81002 | <1% | 14,024 | $1K | |
| 93000 | <1% | 220 | $1K | |
| 90674 | <1% | 198 | $1K | |
| 99348 | <1% | 741 | $1K | |
| 83026 | <1% | 4,749 | $1K | |
| 92081 | <1% | 551 | $1K | |
| 90621 | <1% | 141 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 301 | $1K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 5,285 | $1K |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | <1% | 1,254 | $1K |
| G8482 | Influenza immunization administered or previously received | <1% | 2,755 | $774.08 |
| 99386 | <1% | 48 | $743.20 | |
| 90696 | <1% | 224 | $712.04 | |
| 97802 | <1% | 423 | $636.15 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 424 | $612.95 |
| 99334 | <1% | 243 | $605.65 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 677 | $571.21 |
| 99382 | <1% | 55 | $560.39 | |
| 99406 | <1% | 564 | $538.22 | |
| G0468 | Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv | <1% | 28 | $531.87 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 348 | $515.22 |
| 86580 | <1% | 214 | $510.50 | |
| 87070 | <1% | 881 | $509.86 | |
| 90671 | <1% | 619 | $503.02 | |
| 99385 | <1% | 92 | $410.70 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 4,980 | $394.69 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 2,101 | $387.68 |
| 90700 | <1% | 124 | $385.19 | |
| 3074F | <1% | 1,884 | $370.08 | |
| G8430 | Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status) | <1% | 2,833 | $341.88 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 289 | $332.49 |
| 99205 | Prolong outpt/office vis | <1% | 14 | $331.67 |
| 90732 | <1% | 42 | $309.12 | |
| 81001 | <1% | 1,173 | $303.71 | |
| 92551 | <1% | 621 | $276.38 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 349 | $272.24 |
| 90716 | <1% | 76 | $255.01 | |
| 59430 | <1% | 13 | $241.92 | |
| 3078F | <1% | 1,851 | $216.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 52 | $205.80 |
| 0052A | <1% | 17 | $201.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 283 | $187.14 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 175 | $178.85 |
| V5008 | Hearing screening | <1% | 83 | $172.74 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 1,532 | $171.97 |
| 96127 | <1% | 500 | $169.29 | |
| 90756 | <1% | 13 | $167.06 | |
| 85018 | <1% | 700 | $143.70 | |
| 90707 | <1% | 12 | $139.48 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 506 | $99.89 |
| 99381 | <1% | 93 | $90.21 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | <1% | 452 | $83.54 |
| 86592 | <1% | 430 | $79.82 | |
| 99335 | <1% | 94 | $65.24 | |
| 72100 | <1% | 43 | $59.98 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,869 | $56.70 |
| G8783 | Normal blood pressure reading documented, follow-up not required | <1% | 1,113 | $49.08 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 50 | $49.02 |
| G2011 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes | <1% | 249 | $44.43 |
| 99347 | <1% | 27 | $38.20 | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 310 | $36.00 |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 137 | $32.40 |
| 90461 | <1% | 1,927 | $31.22 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 37 | $30.73 |
| 11719 | <1% | 190 | $30.29 | |
| 1126F | <1% | 121 | $27.25 | |
| 90649 | <1% | 13 | $27.00 | |
| 11720 | <1% | 12 | $18.74 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 126 | $16.00 |
| G9744 | Patient not eligible due to active diagnosis of hypertension | <1% | 299 | $10.31 |
| 90619 | <1% | 14 | $9.02 | |
| G8484 | Influenza immunization was not administered, reason not given | <1% | 110 | $9.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 26 | $6.42 |
| 86486 | <1% | 14 | $4.48 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | <1% | 428 | $3.36 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | <1% | 27 | $3.36 |
| 90655 | <1% | 460 | $0.31 | |
| 90661 | <1% | 78 | $0.14 | |
| 90620 | <1% | 93 | $0.12 | |
| 91301 | <1% | 788 | $0.01 | |
| 90713 | <1% | 12 | $0.01 | |
| 91303 | 0% | 67 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 282 | $0.00 |
| D1206 | Topical application of fluoride varnish | 0% | 111 | $0.00 |
| Z1034 | 0% | 238 | $0.00 | |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 802 | $0.00 |
| 1000F | 0% | 79 | $0.00 | |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 44 | $0.00 |
| D0210 | Intraoral - complete series of radiographic images | 0% | 44 | $0.00 |
| D1330 | 0% | 399 | $0.00 | |
| G8433 | Screening for depression not completed, documented patient or medical reason | 0% | 109 | $0.00 |
| 1036F | 0% | 233 | $0.00 | |
| 90688 | 0% | 37 | $0.00 | |
| D0140 | Limited oral evaluation - problem focused | 0% | 23 | $0.00 |
| 1170F | 0% | 274 | $0.00 | |
| D0150 | Comprehensive oral evaluation - new or established patient | 0% | 233 | $0.00 |
| 90381 | 0% | 14 | $0.00 | |
| 3044F | 0% | 61 | $0.00 | |
| 84153 | 0% | 13 | $0.00 | |
| D9215 | 0% | 442 | $0.00 | |
| 0519 | 0% | 27 | $0.00 | |
| D1310 | 0% | 315 | $0.00 | |
| 1125F | 0% | 24 | $0.00 | |
| 91306 | 0% | 166 | $0.00 | |
| 91305 | 0% | 88 | $0.00 | |
| 3008F | 0% | 131 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 74 | $0.00 |
| 2000F | 0% | 79 | $0.00 | |
| 99422 | 0% | 71 | $0.00 | |
| 3048F | 0% | 35 | $0.00 | |
| 3079F | 0% | 18 | $0.00 | |
| D0120 | Dental checkup, returning patient | 0% | 32 | $0.00 |
| D1120 | Dental cleaning, child | 0% | 19 | $0.00 |
| 1032F | 0% | 38 | $0.00 | |
| G9904 | Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason) | 0% | 97 | $0.00 |
| 91300 | 0% | 978 | $0.00 | |
| 99173 | 0% | 132 | $0.00 | |
| 0005F | 0% | 16 | $0.00 | |
| D0180 | 0% | 120 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 34 | $0.00 |
| 0521 | 0% | 13 | $0.00 | |
| 59425 | 0% | 17 | $0.00 | |
| D0270 | 0% | 24 | $0.00 | |
| 99201 | 0% | 13 | $0.00 | |
| D1110 | Prophylaxis - adult | 0% | 22 | $0.00 |
| 1159F | 0% | 30 | $0.00 | |
| D0274 | Bitewings - four radiographic images | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAREVIAN, SHAUNT (CEO)
| Provider | Location | Paid |
|---|---|---|
| The Roads Foundation, INC | Long Beach, CA | $9K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.